Harrow, Inc. (HROW)
28.44
+0.29
(+1.03%)
USD |
NASDAQ |
Oct 23, 16:00
28.43
-0.01
(-0.04%)
Pre-Market: 20:00
Harrow Net Income (Quarterly) : -17.27M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -17.27M |
| March 31, 2026 | -27.60M |
| December 31, 2025 | 6.626M |
| September 30, 2025 | 1.02M |
| June 30, 2025 | 4.995M |
| March 31, 2025 | -17.78M |
| December 31, 2024 | 6.777M |
| September 30, 2024 | -4.22M |
| June 30, 2024 | -6.473M |
| March 31, 2024 | -13.56M |
| December 31, 2023 | -9.148M |
| September 30, 2023 | -4.391M |
| June 30, 2023 | -4.229M |
| March 31, 2023 | -6.643M |
| December 31, 2022 | 1.055M |
| September 30, 2022 | -6.464M |
| June 30, 2022 | -6.239M |
| March 31, 2022 | -2.438M |
| December 31, 2021 | -7.418M |
| September 30, 2021 | -8.328M |
| June 30, 2021 | -2.478M |
| March 31, 2021 | 0.217M |
| December 31, 2020 | 1.141M |
| September 30, 2020 | 8.623M |
| June 30, 2020 | -0.26M |
| Date | Value |
|---|---|
| March 31, 2020 | -12.92M |
| December 31, 2019 | 2.592M |
| September 30, 2019 | -11.63M |
| June 30, 2019 | -2.42M |
| March 31, 2019 | 11.33M |
| December 31, 2018 | 18.13M |
| September 30, 2018 | -2.514M |
| June 30, 2018 | 2.522M |
| March 31, 2018 | -3.513M |
| December 31, 2017 | -2.771M |
| September 30, 2017 | -5.692M |
| June 30, 2017 | 1.484M |
| March 31, 2017 | -5.006M |
| December 31, 2016 | -6.102M |
| September 30, 2016 | -3.85M |
| June 30, 2016 | -4.639M |
| March 31, 2016 | -4.496M |
| December 31, 2015 | -5.124M |
| September 30, 2015 | -3.952M |
| June 30, 2015 | -3.73M |
| March 31, 2015 | -3.093M |
| December 31, 2014 | -2.745M |
| September 30, 2014 | -2.452M |
| June 30, 2014 | -2.596M |
| March 31, 2014 | -2.325M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Viatris, Inc. | -118.80M |
| 60 Degrees Pharmaceuticals, Inc. | -2.263M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 70.66M |
| Total Expenses (Quarterly) | 87.93M |
| EPS Diluted (Quarterly) | -0.4624 |
| Enterprise Value | 1.283B |
| Gross Profit Margin (Quarterly) | 71.27% |
| Profit Margin (Quarterly) | -24.44% |
| Earnings Yield | -3.51% |
| Operating Earnings Yield | 0.53% |
| Normalized Earnings Yield | -2.465 |